However, despite its many positive effects, IL-6 is also associated with the development of hepatocellular carcinoma (HCC) after liver cirrhosis and elevated serum levels of IL-6 predict HCC progression in patients with chronic hepatitis B infection [45]. This evidence concerns the gene IL6 and hepatocellular carcinoma.